Literature DB >> 26139426

Anti-mullerian hormone (AMH) is associated with natural menopause in a population-based sample: The CARDIA Women's Study.

Sangeeta Nair1, James C Slaughter2, James G Terry1, Duke Appiah3, Imo Ebong4, Erica Wang5, David S Siscovick6, Barbara Sternfeld7, Pamela J Schreiner3, Cora E Lewis8, Edmond K Kabagambe9, Melissa F Wellons10.   

Abstract

OBJECTIVE: AMH is associated with menopausal timing in several studies. In contrast to prior studies that were restricted to women with regular cycles, our objective was to examine this association in women with either regular or irregular menstrual cycles.
METHODS: CARDIA is a longitudinal, population-based study that recruited adults ages 18-30 when it began in 1985-1986. AMH was measured in serum stored in 2002-2003. Natural menopause was assessed by survey in 2005-2006 and 2010-2011.
RESULTS: Among 716 premenopausal women, median [25th, 75th] AMH was 0.77 [0.22-2.02]ng/dL at a median age of 42 [39-45] years. Twenty-nine percent of the women (n=207) reported natural menopause during 9 years of follow up. In fully adjusted discrete-time hazard models, a 0.5 ng/dL AMH decrement was associated with higher risk of menopause (p<0.001). Hazard ratios varied with time since AMH measurement. The HR (95% CI) for menopause was 8.1 (2.5-26.1) within 0-3 years and 2.3 (1.7-3.3) and 1.6 (1.3-2.1) for 3-6 and 6-9 years, respectively. When restricted to women with regular menses, results were similar (e.g., HR=6.1; 95% CI: 1.9-20.0 for 0-3 years).
CONCLUSION: AMH is independently associated with natural menopause. AMH appears most useful in identifying women at risk of menopause in the near future (within 3 years of AMH measurement).
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Anti-mullerian hormone; CARDIA; FSH; Menopause; Ovarian aging; Ovarian reserve

Mesh:

Substances:

Year:  2015        PMID: 26139426      PMCID: PMC4515384          DOI: 10.1016/j.maturitas.2015.06.026

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   5.110


  25 in total

1.  Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women.

Authors:  Bjarne K Jacobsen; Ivar Heuch; Gunnar Kvåle
Journal:  Am J Epidemiol       Date:  2003-05-15       Impact factor: 4.897

Review 2.  The dynamics of the primordial follicle reserve.

Authors:  Jeffrey B Kerr; Michelle Myers; Richard A Anderson
Journal:  Reproduction       Date:  2013-10-21       Impact factor: 3.906

3.  Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women.

Authors:  Ellen W Freeman; Mary D Sammel; Hui Lin; Clarisa R Gracia
Journal:  J Clin Endocrinol Metab       Date:  2012-02-29       Impact factor: 5.958

4.  Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women.

Authors:  S L Broer; M J C Eijkemans; G J Scheffer; I A J van Rooij; A de Vet; A P N Themmen; J S E Laven; F H de Jong; E R Te Velde; B C Fauser; F J M Broekmans
Journal:  J Clin Endocrinol Metab       Date:  2011-05-25       Impact factor: 5.958

5.  Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion.

Authors:  S J Richardson; V Senikas; J F Nelson
Journal:  J Clin Endocrinol Metab       Date:  1987-12       Impact factor: 5.958

6.  Predicting age at menopause from serum antimüllerian hormone concentration.

Authors:  Fahimeh Ramezani Tehrani; Nezhat Shakeri; Masoud Solaymani-Dodaran; Fereidoun Azizi
Journal:  Menopause       Date:  2011-07       Impact factor: 2.953

7.  Antral follicle count predicts natural menopause in a population-based sample: the Coronary Artery Risk Development in Young Adults Women's Study.

Authors:  Melissa F Wellons; Gordon Wright Bates; Pamela J Schreiner; David S Siscovick; Barbara Sternfeld; Cora E Lewis
Journal:  Menopause       Date:  2013-08       Impact factor: 2.953

8.  Modeling age at menopause using serum concentration of anti-mullerian hormone.

Authors:  Fahimeh Ramezani Tehrani; Masoud Solaymani-Dodaran; Maryam Tohidi; Mahmood Reza Gohari; Fereidoun Azizi
Journal:  J Clin Endocrinol Metab       Date:  2013-01-11       Impact factor: 5.958

Review 9.  Racial and ethnic differences in the physiology and clinical symptoms of menopause.

Authors:  Gloria Richard-Davis; Melissa Wellons
Journal:  Semin Reprod Med       Date:  2013-08-09       Impact factor: 1.303

10.  CARDIA: study design, recruitment, and some characteristics of the examined subjects.

Authors:  G D Friedman; G R Cutter; R P Donahue; G H Hughes; S B Hulley; D R Jacobs; K Liu; P J Savage
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

View more
  16 in total

1.  Anti-Müllerian hormone, follicle stimulating hormone, antral follicle count, and risk of menopause within 5 years.

Authors:  Catherine Kim; James C Slaughter; Erica T Wang; Duke Appiah; Pamela Schreiner; Benjamin Leader; Ronit Calderon-Margalit; Barbara Sternfeld; David Siscovick; Melissa Wellons
Journal:  Maturitas       Date:  2017-05-01       Impact factor: 4.342

2.  Modeling Variation in the Reproductive Lifespan of Female Adolescent and Young Adult Cancer Survivors Using AMH.

Authors:  H Irene Su; Brian Kwan; Brian W Whitcomb; Ksenya Shliakhsitsava; Andrew C Dietz; Shaylyn S Stark; Elena Martinez; Patrick M Sluss; Mary D Sammel; Loki Natarajan
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

3.  Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIV.

Authors:  Sara E Looby; Kathleen V Fitch; Suman Srinivasa; Janet Lo; Danielle Rafferty; Amanda Martin; Judith C Currier; Steven Grinspoon; Markella V Zanni
Journal:  AIDS       Date:  2016-01-28       Impact factor: 4.177

4.  Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife.

Authors:  Monika Sarkar; Melissa Wellons; Marcelle I Cedars; Lisa VanWagner; Erica P Gunderson; Veeral Ajmera; Laura Torchen; David Siscovick; J Jeffrey Carr; James G Terry; Mary Rinella; Cora E Lewis; Norah Terrault
Journal:  Am J Gastroenterol       Date:  2017-03-14       Impact factor: 10.864

5.  Self-collected dried blood spots as a tool for measuring ovarian reserve in young female cancer survivors.

Authors:  S C Roberts; S M Seav; T W McDade; S A Dominick; J R Gorman; B W Whitcomb; H I Su
Journal:  Hum Reprod       Date:  2016-05-11       Impact factor: 6.918

6.  Effects of perfluorinated chemicals on thyroid function, markers of ovarian reserve, and natural fertility.

Authors:  Natalie M Crawford; Suzanne E Fenton; Mark Strynar; Erin P Hines; David A Pritchard; Anne Z Steiner
Journal:  Reprod Toxicol       Date:  2017-01-19       Impact factor: 3.143

7.  Effect of In Vitro Maturation of Human Oocytes Obtained After Controlled Ovarian Hormonal Stimulation on the Expression of Development- and Zona Pellucida-Related Genes and Their Interactions.

Authors:  Jure Bedenk; Tadeja Režen; Nina Jančar; Ksenija Geršak; Irma Virant Klun
Journal:  Reprod Sci       Date:  2022-08-01       Impact factor: 2.924

Review 8.  The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility.

Authors:  Jure Bedenk; Eda Vrtačnik-Bokal; Irma Virant-Klun
Journal:  J Assist Reprod Genet       Date:  2019-11-21       Impact factor: 3.412

9.  The association of parity and breastfeeding with anti-Müllerian hormone levels at two time points.

Authors:  Nydjie P Grimes; Brian W Whitcomb; Katherine W Reeves; Lynnette L Sievert; Alexandra Purdue-Smithe; JoAnn E Manson; Susan E Hankinson; Bernard A Rosner; Elizabeth R Bertone-Johnson
Journal:  Maturitas       Date:  2021-09-20       Impact factor: 4.342

10.  Antimullerian Hormone and Impending Menopause in Late Reproductive Age: The Study of Women's Health Across the Nation.

Authors:  Joel S Finkelstein; Hang Lee; Arun Karlamangla; Robert M Neer; Patrick M Sluss; Sherri-Ann M Burnett-Bowie; Karin Darakananda; Patricia K Donahoe; Sioban D Harlow; Sarah H Prizand; Hadine Joffe; Ajay Kumar; Deborah E Martin; Daniel McConnell; Steffenie Merrilat; Anthony Morrison; Lisa M Pastore; John F Randolph; Gail A Greendale; Nanette Santoro
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 6.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.